Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response

Overview of attention for article published in Hematology Transfusion and Cell Therapy, January 2011

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Molecular BCR::ABL1 Quantification and ABL1 Mutation Detection as Essential Tools for the Clinical Management of Chronic Myeloid Leukemia Patients: Results from a Brazilian Single-Center Study

Article in International Journal of Molecular Sciences (June 2023)

Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia

Article in Leukemia Research Reports (May 2022)

Análise da resposta molecular aos 3 e 6 meses de tratamento com mesilato de imatinibe em pacientes com leucemia mieloide crônica acompanhados no Serviço de Hematologia e Hemoterapia do Departamento de Clínica Médica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Article (July 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.